Ahmet Dirican, Professor of Medical Oncology at Medicana International İzmir Hospital, shared a post on X:
“Clear message from Benedikt Westphalen at the 13th Turkish Medical Oncology Congress:
NGS is no longer optional – it’s a cornerstone of modern oncology
But the real challenge is patient selection.
Clinical benefit is modest, costs are high – Molecular Tumor Boards are critical.”
Other articles featuring Ahmet Dirican on OncoDaily.